Norrie's disease (NDP)l was first described in 19272 and, though rare, is well known as an X-linked disorder in which affected males have bilateral leucocoria evident in early infancy or even at birth. The leucocoria is due to a primary retinal dysplasia and resultant total retinal detach ment. Such detachments are of early onset and have been observed by in utero ultrasonograph/ (Fig. I) . Secondary glaucoma, cataract and eventual microphthalmos occur and are associated, in about one third of cases, with pro gressive sensorineural deafness. Mental retardation and psychotic behaviour in late childhood is a variable fea ture. 4 Carrier females rarely have any biochemical, ocular or systemic abnormality.
In the past few years, huge progress has been made in our understanding of the disease through the application of modern molecular genetic techniques. This article sur veys the progress made in our understanding of NDP and, in so doing, discusses some of the phenomena unique to the X-linked disorders.
GENETIC MAPPING OF TH E NDP GENE
The NDP gene is located on the short arm of the X chro mosome, close to the centromere. The disease locus lies within a region (Xp 11.4-p 11.3) to which other ocular dis eases such as XL retinitis pigmentosa (XLRP). congenital stationary night blindness, XL cone dystrophy and XL familial exudative vitreoretinopathy also map (Fig. 2) .
Since 1985, a series of linkage studies and deletion (Fig. 3 ). Tight linkage was described to the DNA probe Ll.285 (often referred to as the X chromosome marker, DXS7). Linkage implies that two genetic loci are transmitted together through the generations of a pedigree more often than would be expected by chance -tightly linked loci are physically very close on the same chromosome. By observing meiotic recombination events between the accurately located DXS7 locus and the unknown NDP locus, it was calculated that the two were highly likely to lie within approximately I megabase (I Mb, one million nucleotide base pairs) of one another. Several patients have been described with proximal Xp deletions which include the DXS7 locus6 or with sub microscopic deletions involving the monoamine oxidase genes MAOA & B.7 DNA polymorph isms within MAOA & B� are therefore also closely linked to NDP and their use as DNA markers in informative pedigrees has enabled more accurate carrier risk estimation and the ability either to diagnose or to exclude Norrie's disease in the male fetus of a carrier female.
The search for more closely linked DNA markers which flank the gene in effect "brackets' the gene locus, and allows the application of techniques that examine gen- 
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PHYSICAL MAPPING AND CLON ING OF TH E NDPGE NE
There are two complementary approaches to the cloning of disease genes; functional cloning and positional clon ing. 9 The former refers to a procedure in which a protein, previously isolated and characterised, is implicated in the aetiology of a disease and is used as the starting point for the isolation of the gene which encodes it. As no protein was previously implicated in the development of Norrie's disease, the method of functional cloning was not applicable to the search for the gene involved. Positional cloning, however, is feasible once a Men delian disorder (i.e. one due to a defect in a single gene) has been mapped genetically using closely linked DNA markers and the disease gene localised to a specific chromosomal region. In the case of Norrie's disease, the map ping of deletions, together with data from linkage analysis, led to accurate localisation of the NDP gene within 150 kb (150 000 nucleotide base pairs). 8 The next step required the utilisation of a specialised vector, the Yeast Artificial Chromosome (YAC) and a screening procedure using complementary DNA (cDNA) libraries from human retina I O (Fig. 4) . cDNA libraries are derived from the messenger RNA (mRNA) of a specific tissue; the reverse transcription of the tissue-specific mRNA is accomplished with enzymes and the unique DNA sequences are then spliced into the DNA of a host vector (e.g. bacteriophage) which allows storage and sub sequent retrieval of the cloned cDNA when required.
Chen et al.11 isolated a Y AC containing DXS7, MAOA & B and NDP and obtained from it, by means of restriction enzymes and specialised electrophoresis, a 160 kb frag ment of DNA believed to contain all or part of the NDP gene. This was used to isolate several cDNAs from libraries derived from fetal and adult retinal mRNA. Of particular interest was one clone which was shown to hybridise to digests from a wide variety of organisms, including species as distant as the fruit-fly Drosophila. This suggested that evolution has maintained the DNA sequence in different species (it is said to be highly con served) and indicates its probable importance to these organisms. The cDNA detected deletions in several affected males -including some not previously known to have deletions -and was therefore identified as a can didate gene for Norrie's disease.
NDP GENE STRUCTURE AND PROTEIN PRODUCT
The NDP gene is small and has three exons, the first of which does not code for any portion of the final protein product (i.e. it is not translated). 10 Within exons 2 and 3 there is an open reading frame of 399 bp which encodes a protein chain of 133 amino acids (Fig. 5) . As with many other ocular genes, NDP is expressed in extraocular tis sues and has been shown to be expressed in adult and fetal brain, fetal lung and adult muscle. Seventy-five per cent of point mutations observed have occurred in exon 3, although intrafamily variation in phenotype makes it difficult to correlate physical signs in affected males with mutation position. However, some cases with atypical Norrie's phenotype have large dele tions and may be examples of a contiguous gene syn drome. 6 The altered phenotype may be the result of co-deletion of the MAO loci as well as other, as yet undefined, genes.
The encoded protein has homology to a protein domain thought to be involved in cellular adhesion.12 Other pro teins which share homologous regions include mucins (a family of extracellular proteins), the Drosophila slit pro tein (an extracellular protein involved in glial develop ment) and von Willebrand coagulation factor. These proteins show conservation of cysteine residues suggest ing that they share an identical arrangement of disulphide bridges. More recent comparative studies indicate that the NDP protein shares homology and a predicted three dimensional structure with a carboxy-terminal domain (termed the cysteine knot) found as a component in a variety of cysteine-rich neurotrophins such as transfor ming growth factor (TGF) and nerve growth factor. 13 On this basis it has been predicted that the dimerisation of the NDP protein may be an essential element in providing the recognition signals for targeting of neuronal/retinal connections.
X-LIN KED DISEASE AND AFFECTED FEMALES
Most X-linked disorders characteristically affect only males. Carrier females are unaffected but may be distin guishable clinically as in the cases of XLRP, ocular albi nism and choroideraemia. In certain circumstances, however, X-linked diseases may actually manifest in the female. In so-called X-linked dominant disorders (such as incontinentia pigmenti and pyruvate dehydrogenase defi ciency) the effects are so severe that males rarely survive and the disorders manifest in heterozygous females. On rare occasions a female may be homozygous for an X-linked disease locus (or in Turner's syndrome, hemi zygous XO) and will therefore manifest the disease. Another mechanism leading to an X-linked disease occurring in a female is unbalanced X chromosome inactivation. In order to equalise the genetic contribution of the sex chromosomes in the two sexes, all female somatic cells inactivate one X chromosome, a process termed Lyonisation.14 Although a random process, selec tion or chance may result in biased inactivation towards one X chromosome. Should a mutation-carrying X chro mosome be active in a sufficient proportion of cells in the tissue in which a gene is expressed then a female may manifest the disease. A family with Norrie's disease has been investigated in which an obligate carrier female had two affected children, one male and one female. I S Measurements of the X-inactivation ratio in the affected daughter suggested that in her peripheral lymphocytes a majority of cells had the mutant X chromosome active. It is likely that this phenomenon, a chance event, is paral leled in her retinal cells and accounts for her manifestation of the disease.
Another female has been described with Norrie's disease associated with a reciprocal X:autosome trans location t(X:1O)(pll:pI4). 16 Females suffering from many X-linked diseases as a result of X:autosome trans locations have now been described. In these cases, those cells which have inactivated the translocated X chro mosome will have a partial autosomal monosomy and a partial X chromosome disomy and will not survive. 17 In the case of the female with Norrie's disease it is assumed that the translocation passes through the Norrie's disease locus and, as all her cells have that X chromosome remain ing active, none will have an active, intact copy of the gene (Fig. 6) .
ALLELIC VARIAN TS OF NORRIE'S DISEASE; X-LIN KED FAMILIAL VITREORETIN OPATHY
Linkage to the region around the NOP locus has been described for two other related disorders: X-linked famil ial vitreoretinopathy (FEVR) I X and X-linked retinal dys plasia.1 9 The familial exudative retinopathies are a small group of disorders and both autosomal and X-linked forms are described. They are characterised by a variable picture of retinal folds, fibrovascular masses, white intraretinal deposits, subretinal exudates and retinal detachment. Some individuals have subclinical disease, others develop symptomatic changes in early adulthood and still others develop phthisis bulbi, end-stage disease. The X-linked form is the least common with few reported pedigrees. X-linked retinal dysplasia is a rare disorder with retinal folds, nystagmus and early-onset blindness in males.
Recently, a mutation in exon 3 of the NOP gene, which is not seen in normal controls, has been described in all affected individuals in one family with FEVR.20 This sug gests that different retinal phenotypes may be associated with mutations in the NOP gene, a situation now recog nised for a variety of other retinal proteins; autosomal dominant (ADRP) and sectoral RP, autosomal recessive RP and congenital stationary night blindness have all been shown to be associated with rhodopsin mutations. [21] [22] [23] Mutation analysis in patients with a variety of inherited retinal disorders has now led to the peripherin protein being implicated in the aetiology of ADRP,24 adult vitelli form macular dystrophy,25 autosomal dominant retinitis punctata albescens26 and butterfly-shaped pigment dys trophy. 27 It is likely that in the future the classification of these inherited retinal and ocular disease phenotypes will rely on DNA molecular analysis as well as clinical assessment.
CON CLUSION S
In the past two to three years huge advances have been made, through molecular genetics, in our understanding of Norrie's disease. In a short space of time we have pro gressed from a knowledge of the approximate position of the gene through linkage analysis to a detailed understand ing of the gene, its mutations and the associated pheno types. As a result, we are now beginning to understand the chemistry of the protein which it encodes and, although much is still to be learned in this field, it is to be hoped that we will soon understand how defects of this gene cause retinal dysplasia.
With the explosion in the number of described, mapped and highly informative DNA polymorphisms it is now possible to define whether a child (born or unborn) has inherited a disease-causing mutation. This system of analysis does have limitations. First, a given polymorphic locus may not demonstrate differences between individ uals in the family under examination, i.e. it may be unin formative. Second, in general, for this type of analysis to be reliable, a fairly large number of individuals from a family need to be analysed. However, the cloning of a disease gene allows direct detection of a mutation and whole pedigrees need not be examined. An affected indi vidual's DNA may be all that is required. Once a mutation has been detected, then carrier detection and prenatal diag nosis for the rest of the family is relatively simple and extremely reliable. Norrie's disease, with a relatively small gene and most mutations localised to one exon, is now in this category.
As more and more of the genes involved in the patho genesis of ophthalmic diseases are identified, this will allow a new level of understanding of their pathogenesis and also, perhaps more interestingly, of ocular develop ment and biochemistry. In the short term this will allow improvements to be made in diagnosis, prenatal diagnosis and in the assessment of prognosis. It is to be hoped that this may in tum lead to progress in treatment, both conven tional and perhaps genetic.
